Aethlon Medical (AEMD) Reports Q2 Loss of $0.15

Aethlon Medical (NASDAQ: AEMD) reported Q2 EPS of ($0.15), versus ($1.29) reported last year.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)
• Arrive AI and DXC Technology partner to bring delivery tech to factories